Cites del registre
Cita APA (7th ed.)
Nguyen, D., Jabbour, E., Kantarjian, H. M., Macaron, W., Jain, N., Nasnas, C., . . . Short, N. J. (2026). Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia. Ferrata Storti Foundation.
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Nguyen, Daniel, et al. Impact of High-sensitivity Next-generation Sequencing, Measurable Residual Disease and Subsequent Stem Cell Transplant in Patients Receiving Blinatumomab for MRD-positive B-cell Acute Lymphoblastic Leukemia. Ferrata Storti Foundation, 2026.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Nguyen, Daniel, et al. Impact of High-sensitivity Next-generation Sequencing, Measurable Residual Disease and Subsequent Stem Cell Transplant in Patients Receiving Blinatumomab for MRD-positive B-cell Acute Lymphoblastic Leukemia. Ferrata Storti Foundation, 2026.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.